Iodine (131I) derlotuximab biotin

N/A

Report date: 2025/09/04 17:54:01

Base Information

Drug NameIodine (131I) derlotuximab biotin
Drug Alias Nameiodine(131I) tumor necrosis factor monoclonal antibody碘[131I]肿瘤细胞核人鼠嵌合单抗Iodine-131 radiolabelled TNT monoclonal antibody碘[131I]肿瘤细胞核人鼠嵌合单克隆抗体131-I-chTNT-1/B mAb +[11] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Iodine > 131I +[4] 
Mechanisms of ActionIonising radiation emitters
TargetsHistoneDNA
Therapy Area/IndicationsLung NeoplasmsGlioblastoma
Global Approved IndicationsLung Neoplasms
Approved Indications in ChinaLung Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2006/08/31
Country/TerritoryUnited StatesIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Moln Biological Technology Co LtdPeregrine
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Moln Biological Technology Co Ltd
Inactive CompaniesAvid Bioservices Inc
Active IndicationsLung Neoplasms
Inactive IndicationsGlioblastoma

Other Information

ATC CodeL01XC
Related LinksN/A